Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1996 1
1997 2
1998 3
1999 3
2002 2
2003 4
2004 2
2005 2
2006 5
2007 5
2008 3
2009 3
2010 6
2011 2
2012 5
2013 4
2014 1
2015 4
2016 7
2017 9
2018 7
2019 11
2020 13
2021 16
2022 20
2023 14
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Exercise management in type 1 diabetes: a consensus statement.
Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, Kowalski A, Rabasa-Lhoret R, McCrimmon RJ, Hume C, Annan F, Fournier PA, Graham C, Bode B, Galassetti P, Jones TW, Millán IS, Heise T, Peters AL, Petz A, Laffel LM. Riddell MC, et al. Among authors: mccrimmon rj. Lancet Diabetes Endocrinol. 2017 May;5(5):377-390. doi: 10.1016/S2213-8587(17)30014-1. Epub 2017 Jan 24. Lancet Diabetes Endocrinol. 2017. PMID: 28126459 Review.
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.
Lingvay I, Catarig AM, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ. Lingvay I, et al. Among authors: mccrimmon rj. Lancet Diabetes Endocrinol. 2019 Nov;7(11):834-844. doi: 10.1016/S2213-8587(19)30311-0. Epub 2019 Sep 17. Lancet Diabetes Endocrinol. 2019. PMID: 31540867 Clinical Trial.
Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS, Harrison DJ, Kisielewski D, Cassidy DM, McNeilly AD, Gallagher JR, Walsh SV, Honda T, McCrimmon RJ, Dinkova-Kostova AT, Ashford MLJ, Dillon JF, Hayes JD. Sharma RS, et al. Among authors: mccrimmon rj. Cell Mol Gastroenterol Hepatol. 2017 Dec 13;5(3):367-398. doi: 10.1016/j.jcmgh.2017.11.016. eCollection 2018 Mar. Cell Mol Gastroenterol Hepatol. 2017. PMID: 29552625 Free PMC article.
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial.
Rosenstock J, Emral R, Sauque-Reyna L, Mohan V, Trescolí C, Al Sifri S, Lalic N, Alvarez A, Picard P, Bonnemaire M, Demil N, McCrimmon RJ; SoliMix Trial Investigators. Rosenstock J, et al. Among authors: mccrimmon rj. Diabetes Care. 2021 Jun 28;44(10):2361-70. doi: 10.2337/dc21-0393. Online ahead of print. Diabetes Care. 2021. PMID: 34183429 Free PMC article.
Experimental Models of Impaired Hypoglycaemia-Associated Counter-Regulation.
Sankar A, Khodai T, McNeilly AD, McCrimmon RJ, Luckman SM. Sankar A, et al. Among authors: mccrimmon rj. Trends Endocrinol Metab. 2020 Sep;31(9):691-703. doi: 10.1016/j.tem.2020.05.008. Epub 2020 Jun 17. Trends Endocrinol Metab. 2020. PMID: 32563715 Free article. Review.
Diabetes and cognitive dysfunction.
McCrimmon RJ, Ryan CM, Frier BM. McCrimmon RJ, et al. Lancet. 2012 Jun 16;379(9833):2291-9. doi: 10.1016/S0140-6736(12)60360-2. Epub 2012 Jun 9. Lancet. 2012. PMID: 22683129 Review.
ONWARDS and upwards for basal insulin.
McCrimmon RJ. McCrimmon RJ. Lancet. 2023 Jun 10;401(10392):1904-1905. doi: 10.1016/S0140-6736(23)00825-5. Epub 2023 May 5. Lancet. 2023. PMID: 37156251 No abstract available.
157 results